Optimal plasma progranulin cutoff value for predicting null progranulin mutations in neurodegenerative diseases: a multicenter Italian study (Q50980787)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 26 November 2011

Language	Label	Description	Also known as
English	Optimal plasma progranulin cutoff value for predicting null progranulin mutations in neurodegenerative diseases: a multicenter Italian study	scientific article published on 26 November 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

Optimal plasma progranulin cutoff value for predicting null progranulin mutations in neurodegenerative diseases: a multicenter Italian study (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

0 references

neurodegeneration

1 reference

based on heuristic

inferred from title

Roberta Ghidoni

1

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

11

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

Daniela Galimberti

12

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

13

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

16

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

object named as

Anna Paterlini

6

0 references

Fabrizio Tagliavini

object named as

Fabrizio Tagliavini

14

0 references

Chiara Fenoglio

10

object named as

Chiara Fenoglio

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

Luigi Francesco Agnati

9

object named as

Luigi F Agnati

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

Eleonora Pegoiani

8

object named as

Eleonora Pegoiani

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

Valentina Albertini

5

object named as

Valentina Albertini

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

2

object named as

Elena Stoppani

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

Michela Glionna

7

object named as

Michela Glionna

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

Giacomina Rossi

3

object named as

Giacomina Rossi

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

Giuliano Binetti

15

object named as

Giuliano Binetti

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

4

object named as

Elena Piccoli

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

publication date

26 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

Neurodegenerative Diseases

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

9

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

3

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

121-127

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

Frontotemporal dementia.

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

Molecular pathways of frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

Progranulin Mutations are a Common Cause of FTLD in Northern Italy

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration.

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

Mild cognitive impairment: clinical characterization and outcome

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

A novel deletion in progranulin gene is associated with FTDP-17 and CBS.

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide.

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

Serum biomarker for progranulin-associated frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers.

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

An algorithm for genetic testing of frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

Identifiers

10.1159/000333132

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50980787&oldid=2264532594"